Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Summary

The objective of this study is to compare the efficacy and safety of RGN-137 topical gel with that of placebo gel for treatment of junctional epidermolysis bullosa (JEB) or dystrophic epidermolysis bullosa (DEB).

Timeline

Start

2019-05-22

Primary completion

2021-09-01

Completion

2021-11-23

Outcome

Outcome not reported

Stopped (Business): “Business Decision”

Drugs

Indications